Disturbance of renal copper homeostasis may drive the progression of DKD, and selective Cu(II) chelation can inhibit the activation of abnormal TGF-β1, thereby slowing down the process of RF and mitigating the progression of DKD. Here, TGFB1 is linked to diabetic kidney disease.